Sysmex Corporation (SSMXF)
OTCMKTS · Delayed Price · Currency is USD
13.30
0.00 (0.00%)
Aug 24, 2025, 8:00 PM EDT
Sysmex Market Cap
Sysmex has a market cap or net worth of $8.08 billion as of August 26, 2025. Its market cap has decreased by -18.83% in one year.
Market Cap
8.08B
Enterprise Value
8.02B
Revenue
3.48B
Ranking
n/a
PE Ratio
24.70
Stock Price
$13.30
Market Cap Chart
Since September 5, 1996, Sysmex's market cap has increased from 479.17M to 8.08B, an increase of 1,585.90%. That is a compound annual growth rate of 10.24%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 25, 2025 | 8.17B | -29.40% |
| Dec 30, 2024 | 11.57B | -0.83% |
| Dec 29, 2023 | 11.67B | -8.05% |
| Dec 30, 2022 | 12.69B | -55.08% |
| Dec 30, 2021 | 28.25B | 12.64% |
| Dec 30, 2020 | 25.08B | 75.55% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nika Pharmaceuticals | 972.93M |
| Veradigm | 823.67M |
| Tian'an Technology Group | 682.77M |
| Glass House Brands | 634.05M |
| Elite Pharmaceuticals | 587.83M |
| American Oncology Network | 382.44M |
| CytoDyn | 372.36M |
| Northwest Biotherapeutics | 366.64M |